Financials

  • Market Capitalization 330.99 M
  • Employee 115
  • Founded 2019
  • CEO N/A
  • Website www.artivabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VPZJ0F9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.25
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3099
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
5.91 USD-0.67%-2.31%-3.27%+84.69%355.22 M USD
3146
AGEN
Agenus Inc. - Common Stock
7.43 USD-3.13%-12.49%+5.69%+86.22%334.50 M USD
3152
TTRX
Turn Therapeutics Inc. - Common Stock
11.11 USD-7.42%-10.04%-10.62%+79.19%330.95 M USD
3172
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.44 USD-2.79%-2.79%-12.86%+28.42%325.11 M USD